Vanda Pharmaceuticals, Inc. (VNDA)
6.85
-0.15
(-2.14%)
USD |
NASDAQ |
Apr 06, 13:21
Vanda Pharmaceuticals Total Assets (Quarterly) : 488.95M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 59.02B |
| Eli Lilly & Co. | 112.48B |
| Gossamer Bio, Inc. | 172.25M |
| Arcellx, Inc. | 603.99M |
| AnaptysBio, Inc. | 364.40M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 161.76M |
| Shareholders Equity (Quarterly) | 327.19M |
| Debt to Equity Ratio | 0.0386 |
| Current Ratio | 2.392 |
| Net Debt Paydown Yield | -0.18% |